Publication | Open Access

Anti-proliferative actions of a synthetic REV-ERBα/β agonist in breast cancer cells

Tumor BiologyBreast OncologyMedicineBreast Cancer CellsPharmacologyCancer Cell BiologyAnti-proliferative ActionsSynthetic Rev-erbα/β AgonistBreast CancerAnti-cancer AgentOncologyCell BiologyCancer Research